Search
Search for:
Search for:
Find a Pharmacy
Vertice Login
Menu
About Us
About Us
Our Brand
What We Do
Our People
Contact Us
Careers
FAQ
Workers' Comp Solutions
Workers' Comp Solutions
Pharmacy
Ancillary
Clinical Services
Claims Technology
Claims Technology
Request Demo
Data Analytics
Insights
Insights
RxInformer
Worker's Comprehensive
Clinical Minute
Intelligence
Intelligence
Industry Insights Survey
Industry Insights Survey
2025
2024
2023
2022
2021
2020
2019
Blog
Infographics
Advocacy Compliance
What's Happening
What's Happening
Events
Medmonitor
Social Hub
Customer Center
Customer Center
Pharmacy Search
Ask a Pharmacist
Claims Resources
Claims Resources
Mail Order
Patient Resources
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers
Tag:
drug development
11 posts found
Opioid Developments
Cebranopadol Phase 3 Trials Show Promising Results
A compound opioid/NOP receptor agonist demonstrated pain relief with a safety profile comparable to placebo.
Read More
Innovation
FDA Issues Draft Guidance for the Use of AI in the Creation of Drugs and Medical Devices
The guidelines provide recommendations on using AI to demonstrate drug safety and effectiveness, and recommendations for AI-enabled medical devices.
Read More
Innovation
New Drug in Development Could Help Patients with Spinal Cord Injuries
AZD1236, currently in Phase 2 trials, has shown an 80% preservation in nerve function following spinal cord injury.
Read More
Medmonitor
Phase 2 Trials for Non-Opioid Pain Medication Deliver Promising Results
VX-548 delivered significant improvements in pain with few adverse events.
Read More
COVID-19 Developments
Additional Vaccine Candidate Performs Well in Clinical Trials
Phase 3 trials for NVX-CoV2373 across 30,000 people found this vaccine candidate to be safe and effective for the prevention of COVID-19.
Read More
Clinical Developments
FDA Diagnostic Testing Updates
The FDA is working to expedite the delivery of diagnostic testing for COVID-19.
Read More
Clinical Developments
COVID-19 and Clinical Trials
COVID-19 drug trials are underway, but the pandemic is disrupting clinical testing.
Read More
Medmonitor
FDA Accepts New Drug Application for Opioid NKTR-181
NKTR-181 is supposed to offer a lower frequency of opioid side effects. But are more opioids really the solution we need to the opioid crisis?
Read More
Clinical Insights
New Developments in Migraine Medications
A new wave of drugs that suppress CGRP proteins to reduce migraines could be on the horizon.
Read More
Opioid Developments
FDA Proposes New Clinical Endpoints for Development of Opioid-Use Disorder Drugs
Drugs to treat opioid dependence could be approved under new clinical endpoints other than reducing opioid use.
Read More
Medmonitor
FDA Approves New Opioid Prodrug, Apadaz
Apadaz oral tablets were approved for the short-term management of acute pain, at no more than 14 days of use.
Read More
©
2025
Healthesystems
Workers' Comp Property and Casualty PBM
Expires 01/01/2028
info-circle
caret-right
lock
map-marker
magnifier
cross
menu
arrow-right
cross-circle